ELV vs UNH
ELV and UNH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ELVElevance Health, Inc. | UNHUnitedHealth Group Incorporated |
|---|---|---|
| Market cap | $90.75B | $365.25B |
| P/E (TTM) | 17.8 | 26.2 |
| P/B | 2.03 | 11.06 |
| P/S | — | 0.8x |
| Dividend yield | 1.68% | 2.17% |
| Revenue | $201.83B(TTM) | $450.13B(TTM) |
| Revenue growth (YoY) | — | 11.8% |
| Net income | $5.14B(TTM) | $14.12B(TTM) |
| Earnings growth (YoY) | — | -16.3% |
| EPS, diluted | $23.55(TTM) | $15.56(TTM) |
| EBIT margin | — | 4.2% |
| ROE | — | 36.5% |
| ROIC | — | 21.3% |
| 1y total return | — | +20.6% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ELV vs UNH
| Metric | ELV | UNH |
|---|---|---|
| End value | $36.9K | $34.4K |
| Total return | +268.6% | +243.7% |
| CAGR | +13.4% | +12.7% |
| Volatility | 31.0% | 30.0% |
| Sharpe | 0.43 | 0.41 |
| Sortino | 0.61 | 0.57 |
| Max drawdown | -50.4% | -61.4% |
Based on 2600 common trading days, 2016-06-29 → 2026-10-30 · risk-free 4.16% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)